Emerging Infectious Diseases (Mar 2019)

Multicenter Study of Cronobacter sakazakii Infections in Humans, Europe, 2017

  • Sarah Lepuschitz,
  • Werner Ruppitsch,
  • Shiva Pekard-Amenitsch,
  • Stephen J. Forsythe,
  • Martin Cormican,
  • Robert L. Mach,
  • Denis Piérard,
  • Franz Allerberger

DOI
https://doi.org/10.3201/eid2503.181652
Journal volume & issue
Vol. 25, no. 3
pp. 515 – 522

Abstract

Read online

Cronobacter sakazakii has been documented as a cause of life-threating infections, predominantly in neonates. We conducted a multicenter study to assess the occurrence of C. sakazakii across Europe and the extent of clonality for outbreak detection. National coordinators representing 24 countries in Europe were requested to submit all human C. sakazakii isolates collected during 2017 to a study center in Austria. Testing at the center included species identification by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, subtyping by whole-genome sequencing (WGS), and determination of antimicrobial resistance. Eleven countries sent 77 isolates, including 36 isolates from 2017 and 41 historical isolates. Fifty-nine isolates were confirmed as C. sakazakii by WGS, highlighting the challenge of correctly identifying Cronobacter spp. WGS-based typing revealed high strain diversity, indicating absence of multinational outbreaks in 2017, but identified 4 previously unpublished historical outbreaks. WGS is the recommended method for accurate identification, typing, and detection of this pathogen.

Keywords